Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations.
TL;DR: The present study investigated the distribution of variant p.R4810K in RNF213 in 2,508 participants from East and Southeast Asian countries using a TaqMan probe to find the number of patients with moyamoya disease, which was considered to be 53,800 in East Asian populations.
read more
Abstract: Moyamoya disease is an idiopathic vascular disorder of the intracranial arteries. Ring finger 213 (RNF213) was previously identified as the strongest susceptibility gene for moyamoya disease in East Asian people by a genome-wide linkage analysis and exome analysis. The coding variant p.R4810K in RNF213 was strongly associated with moyamoya disease in the Japanese (odds ratio: 338.94, p = 1.05 × 10(-100)) and Korean (odds ratio: 135.63, p = 7.59 × 10(-27)) populations, and much less strongly associated in the Chinese population (odds ratio: 14.70, p = 2.63 × 10(-5)). The present study investigated the distribution of variant p.R4810K in RNF213 in 2,508 participants from East and Southeast Asian countries using a TaqMan probe. p.R4810K was detected at an allele frequency of about 1.00% in 4 of 11 investigated locations in China. In contrast, p.R4810K was detected homogeneously at relatively high frequencies of 1.00-1.72% in all investigated locations in Korea and Japan, including Okinawa. p.R4810K was not detected in Southeast Asian populations. The population susceptible to moyamoya disease was estimated to be 16.16 million people in East Asian countries, including 11.41 million Chinese, 1.36 million Korean, and 3.39 million Japanese people. The number of patients with moyamoya disease, which was estimated at approximately one per 300 carriers of p.R4810K, was considered to be 53,800 in East Asian populations.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Figures
Citations
Ubiquitylation of lipopolysaccharide by RNF213 during bacterial infection.
Elsje G. Otten,Emma I. Werner,Ana Crespillo-Casado,Keith B. Boyle,Vimisha Dharamdasani,Claudio Pathe,Balaji Santhanam,Balaji Santhanam,Felix Randow,Felix Randow +9 more
TL;DR: In this paper, the ubiquitylation of a non-proteinaceous substrate, the lipid A moiety of bacterial lipopolysaccharide (LPS), by the E3 ubiquitin ligase ring finger protein 213 (RNF213), is shown to be a risk factor for moyamoya disease.
269
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids
Manuele Piccolis,Laura M. Bond,Martin Kampmann,Pamela Pulimeno,Chandramohan Chitraju,Christina B. K. Jayson,Laura Pontano Vaites,Sebastian Boland,Zon Weng Lai,Katlyn R. Gabriel,Katlyn R. Gabriel,Shane D. Elliott,Shane D. Elliott,Joao A. Paulo,J. Wade Harper,Jonathan S. Weissman,Tobias C. Walther,Robert V. Farese,Robert V. Farese +18 more
TL;DR: Analysis of the transcriptome, lipidome, and genetic interactions of human leukemia cells exposed to palmitate revealed that changes in di-saturated glycerolipids, but not other lipid classes, are central to lipotoxicity in this model.
223
Intracranial Atherosclerosis: Current Understanding and Perspectives
TL;DR: Recently large clinical trials of ICAD, which evaluated the effectiveness of anticoagulation and stenting to prevent thromboembolism and restore hemodynamic compromise, failed to reduce major vascular events in patients with ICAD.
The Pathophysiology of Moyamoya Disease: An Update
TL;DR: This review summarizes the recent advances in MMD pathophysiology, including the genetic and circulating factors related to disease development, and possible strategies including targeting growth factors, retinoic acid, caveolin-1, and stem cells.
Moyamoya disease: diagnosis and interventions
TL;DR: In this paper , it was shown that the Arg4810Lys variant of RNF213 is the major susceptibility gene for moyamoya disease, but the penetrance is lower than 1%, suggesting a synergistic relationship with additional environmental and genetic risk factors.
182
References
Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain.
Jiro Suzuki,Akira Takaku +1 more
TL;DR: The disease which produces an abnormal net-like blood vessel picture in the base of the brain might have been observed in this country during these 10 years, but visualization of such an angiogram seems not to have been noticed as indicating a disease with characteristic features.
2.1K
Cerebrovascular "Moyamoya" disease. 2. Collateral routes to forebrain via ethmoid sinus and superior nasal meatus.
Jiro Suzuki,Namio Kodama +1 more
TL;DR: The cases presenting evidence of abnormal net-like vessels at the base of the brain should be regarded as one unit of disease, and have reported repeatedly that the disease is Huntington's disease.
1.7K
Moyamoya disease: current concepts and future perspectives
Satoshi Kuroda,Kiyohiro Houkin +1 more
TL;DR: Extracranial-intracranIAL arterial bypass, including anastomosis of the superficial temporal artery to the middle cerebral artery and indirect bypass, can help prevent further ischaemic attacks, although the beneficial effect on haemorrhagic stroke is still not clear.
1.1K
A genome-wide association study identifies RNF213 as the first Moyamoya disease gene
Fumiaki Kamada,Yoko Aoki,Ayumi Narisawa,Yu Abe,Shoko Komatsuzaki,Atsuo Kikuchi,Junko Kanno,Tetsuya Niihori,Masao Ono,Naoto Ishii,Yuji Owada,Miki Fujimura,Yoichi Mashimo,Yoichi Suzuki,Akira Hata,Shigeru Tsuchiya,Teiji Tominaga,Yoichi Matsubara,Shigeo Kure +18 more
TL;DR: Results indicate that RNF213 is the first identified susceptibility gene for MMD, and it is confirmed that mature lymphocytes express higher levels of Rnf213 mRNA than their immature counterparts.
Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development
Wanyang Liu,Daisuke Morito,Seiji Takashima,Yohei Mineharu,Hatasu Kobayashi,Toshiaki Hitomi,Hirokuni Hashikata,Norio Matsuura,Satoru Yamazaki,Atsushi Toyoda,Ken-ichiro Kikuta,Yasushi Takagi,Kouji H. Harada,Asao Fujiyama,Asao Fujiyama,Roman Herzig,Boris Krischek,Li-Ping Zou,Jeongeun Kim,Masafumi Kitakaze,Susumu Miyamoto,Kazuhiro Nagata,Nobuo Hashimoto,Akio Koizumi +23 more
TL;DR: Evidence is provided suggesting, for the first time, the involvement of RNF213 in genetic susceptibility to moyamoya disease, and a founder haplotype transmitted in 42 families is revealed.
660
Related Papers (5)
Wanyang Liu,Daisuke Morito,Seiji Takashima,Yohei Mineharu,Hatasu Kobayashi,Toshiaki Hitomi,Hirokuni Hashikata,Norio Matsuura,Satoru Yamazaki,Atsushi Toyoda,Ken-ichiro Kikuta,Yasushi Takagi,Kouji H. Harada,Asao Fujiyama,Asao Fujiyama,Roman Herzig,Boris Krischek,Li-Ping Zou,Jeongeun Kim,Masafumi Kitakaze,Susumu Miyamoto,Kazuhiro Nagata,Nobuo Hashimoto,Akio Koizumi +23 more


